Scandinavian ChemoTech AB’s Shares Offering

Moll Wenden advised Scandinavian ChemoTech AB on the deal.Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical technology…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Maha Kanaan

Author: Maha Kanaan

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here